| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5825548 | Clinical Therapeutics | 2006 | 10 Pages |
Abstract
For these CHB patients with lamivudine resistance, lamivudine plus adefovir was a better treatment option than entecavir alone.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Ze-Bing Huang, Shu-Shan Zhao, Yan Huang, Xia-Hong Dai, Rong-Rong Zhou, Pan-Pan Yi, Ruo-Chan Chen, Wen-Ting Li, Bao-Xin Zhang, Ning Li, Xue-Gong Fan,